Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Harvard Business School
Baxter
Covington
AstraZeneca
Fuji
Moodys
Colorcon

Generated: April 25, 2018

DrugPatentWatch Database Preview

VELIVET Drug Profile

« Back to Dashboard

When do Velivet patents expire, and when can generic versions of Velivet launch?

Velivet is a drug marketed by Duramed Pharms Barr and is included in one NDA.

The generic ingredient in VELIVET is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Drug patent expirations by year for VELIVET
Synonyms for VELIVET
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2(7),3,5-TRIENE-5,14-DIOL; (1S,2R,10S,11S,14R,15S)-15-ETHYL-14-ETHYNYL-17-METHYLIDENETETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-1
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol; (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenan
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-, mixt. with (17alpha)-13-ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol
71138-35-7
AC1L1Y41
Apri
C22H30O.C20H24O2
C442659000
Caziant
Cesia
CHEMBL1697756
combiphasic EE-DSG contraceptive
Ctr 24
Cycleane
Desogen (contraceptive)
Desogestrel - ethinylestradiol mixt.
Desogestrel - ethylnylestradiol mixture
Desogestrel - ethynylestradiol mixt.
DESOGESTREL AND ETHINYL ESTRADIOL
Desogestrel mixture with ethinyl estradiol
Desogestrel; ethinyl
DESOGESTREL; ETHINYL ESTRADIOL
Desolett
DTXSID20221336
Emoquette
Ethinyl estradiol and desogestrel
ethinyl estradiol-desogestrel combination
Ethinylestradiol - desogestrel mixt.
Ethinylestradiol mixture with Desogestrel
Gracial
Kalliga
Laurina
Lovelle
LS-178530
Marvelone
Novelon
Org 5187
Ortho Cept
ortho-Cept
OrthoCept
Ovidol
PL067705
Practil 21
Reclipsen
Relivon
SCHEMBL1649231
Securgin

US Patents and Regulatory Information for VELIVET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms Barr VELIVET desogestrel; ethinyl estradiol TABLET;ORAL-28 076455-001 Feb 24, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Daiichi Sankyo
Julphar
Queensland Health
Merck
Accenture
Chinese Patent Office
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.